Behavioral Symptoms Completed Phase 3 Trials for Aripiprazole (DB01238)

IndicationStatusPhase
DBCOND0034705 (Behavioral Symptoms)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00337571Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)Treatment
NCT00365859Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)Treatment